SecBot SecBot
8-K ·Filed Oct 5, 2026

ODYY

Odyssey Health, Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed22d 3h ago SEC0001683168-26-007625
8-K material event: Items 1.01
Actionable Insight • Neutral

Monitor for further maturity extensions or restructuring of these notes as the January 31, 2027 deadline approaches. The 13th amendment to the LGH note suggests repeated reliance on extensions, which may indicate ongoing cash constraints.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled — T+5d
ODYY ▼ -12.50% at T+5d
NEUTRAL call -12.50% · α vs SPY -12.36% · entry $0.008000 → $0.007000
Next anchor: T+20d in 5d
Latest observation: T+13 +45.37% FF3 residual α
Entry = T+0 close
Oct 5, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.24%
$0.008000
settled 22d ago
T+5d
-12.50%
call -12.50% · α -12.36%
$0.007000
settled 16d ago
T+20d
Pending
in 5d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Odyssey Health, Inc. entered into two amendments to extend the maturity dates of existing promissory notes: Amendment No. 13 with LGH Investments, LLC (original $1,050,000 convertible note dated April 2021) and Amendment No. 1 with Peter J. D'Arruda (original $100,000 note dated October 2025). Both maturity dates were extended to January 31, 2027. This is a routine debt maturity extension with no new borrowing or change in terms, indicating the company is managing near-term liquidity but not resolving the underlying obligations.

Key Facts

  • Amendment No. 13 extends the maturity of the $1,050,000 convertible promissory note with LGH Investments, LLC to January 31, 2027.
  • Amendment No. 1 extends the maturity of the $100,000 promissory note with Peter J. D'Arruda to January 31, 2027.
  • All other terms and conditions of both notes remain unchanged.
  • The original convertible note with LGH Investments dates to April 5, 2021, and has been amended 13 times.
  • The original note with Peter J. D'Arruda dates to October 1, 2025, and this is its first amendment.

Financial Impact

No new capital raised; existing obligations of $1,150,000 total principal extended by approximately 4 months.

debt_maturityliquidity

Risk Factors

  • Repeated note extensions may signal difficulty refinancing or repaying obligations.
  • The convertible note with LGH Investments could result in dilution if converted.
  • No new financing or operational update was provided in this filing.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001683168-26-007625
Document: odyssey_ex1001.htm0001683168-26-007625
Document: odyssey_ex1002.htm0001683168-26-007625
Document: 0001683168-26-007625-index-headers.html0001683168-26-007625
Document: 0001683168-26-007625-index.html0001683168-26-007625
Document: 0001683168-26-007625.txt0001683168-26-007625

US Market Status

Market Closed — Opens Thu (12h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 5, 2026